Get started
Author

Roberto Dias de Oliveira

Observed names: Dias de Oliveira, Roberto, Oliveira, Roberto D., Oliveira, Roberto Dias, R.A.R. De Oliveira, R.D. de Oliveira, Roberto Dias Oliveira, Roberto D. Oliveira, Roberto D. de Oliveira, Roberto Dias De Oliveira, Roberto Oliveira, Roberto de Oliveira
Observed institutions: Universidade Federal de Mato Grosso do Sul, Universidade Estadual de Londrina, European Union of Medical Specialists, Royal Children's Hospital, Universidade Federal da Grande Dourados, Universidade Estadual de Mato Grosso do Sul, South Australian Health and Medical Research Institute, Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz
ORCID: 0000-0001-7996-8011
Observed ORCID: 0000-0001-7996-8011
OpenAlex ID: A5043358921
Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study
2021 · Otavio T. Ranzani, Matt D.T. Hitchings, et al. · BMJ · 349
PDF
Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study
2021 · Matt D.T. Hitchings, Otavio T. Ranzani, et al. · The Lancet Regional Health - Americas · 201
PDF
Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers
2023 · Laure F. Pittet, Nicole L. Messina, et al. · New England Journal of Medicine · 133
PDF
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
2022 · Otavio T. Ranzani, Matt D. T. Hitchings, et al. · Nature Communications · 112
PDF
Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo
2021 · Matt D. T. Hitchings, Otavio T. Ranzani, et al. · Nature Communications · 76
PDF
The role of prisons in disseminating tuberculosis in Brazil: A genomic epidemiology study
2022 · Katharine S. Walter, Paulo César Pereira dos Santos, et al. · The Lancet Regional Health - Americas · 55
Yield, Efficiency, and Costs of Mass Screening Algorithms for Tuberculosis in Brazilian Prisons
2020 · Andrea da Silva Santos, Roberto Dias de Oliveira, et al. · Clinical Infectious Diseases · 53
Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial
2024 · Paulo Cesar Pereira dos Santos, Nicole Louise Messina, et al. · The Lancet Infectious Diseases · 48
PDF
Oral swab testing by Xpert® MTB/RIF Ultra for mass tuberculosis screening in prisons
2020 · Fabiano Lima, Andrea S. Santos, et al. · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 43
Effectiveness of the TAK-003 dengue vaccine in adolescents during the 2024 outbreak in São Paulo, Brazil: a test-negative, case–control study
2025 · Otavio T Ranzani, Felippe Lazar Neto, et al. · The Lancet Infectious Diseases · 36
Evaluation of chest X-ray with automated interpretation algorithms for mass tuberculosis screening in prisons: a cross-sectional study
2022 · Thiego Ramon Soares, Roberto Dias de Oliveira, et al. · The Lancet Regional Health - Americas · 30
PDF
Serum biomarkers associated with SARS-CoV-2 severity
2022 · Fabiani de Morais Batista, Marco Antonio Moreira Puga, et al. · Scientific Reports · 29
PDF
Pooling Sputum Samples for Efficient Mass Tuberculosis Screening in Prisons
2021 · Paulo César Pereira dos Santos, Andrea da Silva Santos, et al. · Clinical Infectious Diseases · 26
Serial Mass Screening for Tuberculosis Among Incarcerated Persons in Brazil
2024 · Rafaele Carla Pivetta de Araujo, Leonardo Martinez, et al. · Clinical Infectious Diseases · 20
PDF
Change in covid-19 risk over time following vaccination with CoronaVac: test negative case-control study
2022 · Matt D.T. Hitchings, Otavio T. Ranzani, et al. · BMJ · 18
PDF
BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial
2024 · Nicole L. Messina, Laure F. Pittet, et al. · Journal of Infection · 15
PDF
All-cause and cause-specific mortality during and following incarceration in Brazil: A retrospective cohort study
2021 · Yiran E. Liu, Everton Ferreira Lemos, et al. · PLoS Medicine · 14
Effectiveness of the fourth dose of COVID-19 vaccines against severe COVID-19 among adults 40 years or older in Brazil: a population-based cohort study
2024 · Felippe Lazar Neto, Matt D.T. Hitchings, et al. · The Lancet Regional Health - Americas · 11
Factors influencing adverse events following COVID-19 vaccination
2024 · Paola Villanueva, Ellie McDonald, et al. · Human Vaccines & Immunotherapeutics · 10
Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination
2023 · Nicole L. Messina, Mariana G. Sperotto, et al. · Frontiers in Immunology · 10
Delay in the diagnosis and treatment of tuberculosis in prisons in Mato Grosso do Sul, Brazil
2023 · Carla Celina Ribeiro, Andrea da Silva Santos, et al. · Revista da Sociedade Brasileira de Medicina Tropical · 10
PDF
Primary Prophylaxis to Prevent Tuberculosis Infection in Prison Inmates: A Randomized, Double-Blind, Placebo-Controlled Trial
2020 · Roberto Dias de Oliveira, Andrea da Silva Santos, et al. · American Journal of Tropical Medicine and Hygiene · 10
PDF
Perfil sociodemográfico dos enfermeiros da rede hospitalar
2017 · Marcos Antônio Nunes de Araújo, Wilson Danilo Danilo Lunardi Filho, et al. · Revista de Enfermagem UFPE on line · 9
Infecção pelo vírus da hepatite C em gestantes em Mato Grosso do Sul, 2005-2007
2011 · Clarice Souza Pinto, Regina Maria Bringel Martins, et al. · Revista de Saúde Pública · 9
PDF
Adverse Events and Immunization Errors Following a Mass Immunization Campaignwith TAK‐003 in Dourados, Brazil: A Post‐Marketing Safety Surveillance Analysis
2025 · Luana Clemm Kuhnen Anschau, Amanda Maria Miguel Bortuluzi, et al. · Journal of Medical Virology · 8
PDF
Works count: 61
Citation count: 1,425
H-index: 15
I10-index: 22
Year
Topic
Type